<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>A patient with <z:hpo ids='HP_0001976'>antithrombin III deficiency</z:hpo> developed <z:hpo ids='HP_0002625'>deep vein thrombosis</z:hpo> during her first pregnancy </plain></SENT>
<SENT sid="1" pm="."><plain>Her pregnancy and delivery were successfully treated with simultaneous administration of antithrombin III concentrates and low molecular weight <z:chebi fb="5" ids="28304">heparin</z:chebi> </plain></SENT>
<SENT sid="2" pm="."><plain>She delivered a 2,412g girl at 39 weeks' gestation </plain></SENT>
<SENT sid="3" pm="."><plain>The baby was administered with antithrombin III concentrates as prophylaxis for neonatal arterial and <z:hpo ids='HP_0004936'>venous thrombosis</z:hpo> because the antithrombin III level was extremely low to be 2% </plain></SENT>
<SENT sid="4" pm="."><plain>Her second pregnancy was uneventful at 38 weeks' gestation, and she was treated with administration of antithrombin III concentrates prophylactically </plain></SENT>
<SENT sid="5" pm="."><plain>She delivered a 3,256g boy at 42 weeks' gestation without any complications </plain></SENT>
<SENT sid="6" pm="."><plain>The antithrombin III level of the second baby was <z:mpath ids='MPATH_458'>normal</z:mpath> </plain></SENT>
<SENT sid="7" pm="."><plain>These results showed that in a neonate with congenital <z:hpo ids='HP_0001976'>antithrombin III deficiency</z:hpo> the antithrombin III concentrates would be administered to prevent neonatal arterial and <z:hpo ids='HP_0004936'>venous thrombosis</z:hpo> </plain></SENT>
</text></document>